SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.87-0.2%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (10584)6/29/1999 11:14:00 PM
From: Edscharp  Read Replies (1) of 17367
 
TexasDude,

I'm sure your aware of this, but I'll say it anyway. Technical Analysis (TA) can occasionally be very useful, but in this context I think it is near useless.

If Neuprex fails to perform the stock will drop like a rock. The false assumption is that TA can somehow predict this.

The technical chart looks good because of investor expectations that Neuprex will succeed. If it doesn't succeed TA will quickly reflect the new reality. TA is great if it can predict a stock's movement the day before, not the day after.

TA works a hell of a lot better when a company has earnings.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext